Immediate Impact
1 from Science/Nature 68 standout
Citing Papers
Alcohol-associated liver disease
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Feng Wen being referenced
Cost‐effectiveness analysis of cabozantinib as second‐line therapy in advanced hepatocellular carcinoma
2019
Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Feng Wen | 200 | 215 | 124 | 246 | 52 | 681 | |
| Leonardo Gomes da Fonseca | 171 | 300 | 128 | 329 | 67 | 759 | |
| Adina Croitoru | 120 | 291 | 164 | 239 | 71 | 736 | |
| Scot Dowden | 282 | 614 | 188 | 123 | 24 | 809 | |
| Shuncong Wang | 203 | 337 | 86 | 68 | 38 | 738 | |
| Liming Wang | 119 | 190 | 245 | 280 | 62 | 639 | |
| Vincenzo Dadduzio | 251 | 434 | 189 | 287 | 39 | 802 | |
| Marcus Smith Noel | 129 | 506 | 123 | 71 | 65 | 764 | |
| S. Palmeri | 226 | 577 | 126 | 91 | 77 | 808 | |
| Lothar Müller | 257 | 408 | 96 | 81 | 67 | 821 | |
| Eucario León-Rodrı́guez | 105 | 267 | 88 | 50 | 46 | 612 |
All Works
Login with ORCID to disown or claim papers
Loading papers...